Long-term Metformin Alters Gut Microbiota and Serum Metabolome in Coronary Artery Disease Patients After Percutaneous Coronary Intervention to Improve 5-year Prognoses: A Multi-omics Analysis

Long-term Metformin Alters Gut Microbiota and Serum Metabolome in Coronary Artery Disease Patients After Percutaneous Coronary Intervention to Improve 5-year Prognoses: A Multi-omics Analysis

Background: About 20% of patients with coronary artery disease (CAD) experience adverse events within five years of undergoing percutaneous coronary intervention (PCI) for acute myocardial infarction. In these patients, the impact of metformin on long-term prognosis remains uncert...

Full description

Saved in:
Bibliographic Details
Main Authors: Ruilin Zhou, Qingyang Wu, Hao Qian, Liang Wang, Guangcheng Liu, Bin Zhang, Wei Wu, Shuyang Zhang
Format: Article
Language:English
Published: IMR Press 2025-05-01
Series:Reviews in Cardiovascular Medicine
Subjects:
metformin
gut microbiota
coronary artery disease
diabetes mellitus
multiomic analyses
Online Access:https://www.imrpress.com/journal/RCM/26/5/10.31083/RCM26835
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.imrpress.com/journal/RCM/26/5/10.31083/RCM26835

Similar Items